News | Stent Grafts | May 04, 2022

Reshaping the Future of Cardiac Bypass Surgery With Biocompatible Graft

Medical 21 Files Regulation A+ Offering, accepting invitations for $40 million funding round offering

Artificial graft

Medical 21's artificial graft technology


May 4, 2022 – Seeking to bolster its development of a biocompatible graft that promises to reshape the future of cardiac bypass surgery, Medical 21, a medtech device company, recently announced it has filed a Form 1-A with the U.S. Securities and Exchange Commission (SEC) and is now accepting, from the public, reservations for its $40 million funding round on its website.

Medical 21’s innovative artificial graft eliminates the need of harvesting saphenous vein grafts (SVGs) or other veins and arteries, shortens procedure time, reduces pain, decreases patient recovery time, and avoids scarring, among many other benefits.

Medical 21’s graft technology will not only vastly improve the recovery of heart bypass patients but also assists cardiac surgeons by reducing operating times. The graft provides the flexibility to perform bypass surgery either on the heart-lung bypass machine or “off-pump” and reduces costs associated with wound-related post-operative care and readmissions.

Manny Villafana

Medical 21 was founded by Manny Villafaña, Ph.D. Sc.D., a globally recognized entrepreneur and medical device developer. Known as the co-developer of the St. Jude heart valve and founder of St. Jude Medical, Inc., Villafaña has been named a Living Legend of Medicine by The World Society of CardioThoracic Surgery and is an award-winning USA Master Entrepreneur, a member of the Minnesota Business Hall of Fame, an inductee of the Minnesota Science and Technology Hall of Fame, and recipient of the Medical Design Association Lifetime Achievement Award. Villafaña has led seven of his companies into successful IPOs.

“We see Reg A+ financing as the 21st century way of funding a company and bringing this life-changing solution to market,” said Villafaña. “Despite having an accomplished career in the cardiac health space, Medical 21 is by far the company I’m most excited about because of its enormous potential to improve conditions for the millions of coronary artery heart bypass surgery patients.”

For more information: https://medical21.com/

Related Content

Feature | Cardiovascular Surgery

The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 ...

Home June 14, 2022
Home
News | Cardiovascular Surgery

June 14, 2022 — The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI), a nonprofit organization ...

Home June 14, 2022
Home
News | Cardiovascular Surgery

April 29, 2022 – Paragonix Technologies, Inc., a leading organ preservation provider, announces today groundbreaking ...

Home April 29, 2022
Home
News | Cardiovascular Surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...
Home February 18, 2022
Home
News | Cardiovascular Surgery
February 15, 2022 – A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA ...
Home February 15, 2022
Home
News | Cardiovascular Surgery

February 11, 2022 — Riverside Community Hospital has earned a distinguished three-star rating from The Society of ...

Home February 11, 2022
Home
News | Cardiovascular Surgery

November 23, 2021 — A novel device called venous external support (VEST) may lead to increased longevity and durability ...

Home November 23, 2021
Home
News | Cardiovascular Surgery

November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing ...

Home November 22, 2021
Home
News | Cardiovascular Surgery

November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...

Home November 18, 2021
Home
News | Cardiovascular Surgery

November 18, 2021 — People who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery may ...

Home November 18, 2021
Home
Subscribe Now